These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 34522589)

  • 1. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.
    Han L; Jiang C
    Acta Pharm Sin B; 2021 Aug; 11(8):2306-2325. PubMed ID: 34522589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment.
    Khan NU; Ni J; Ju X; Miao T; Chen H; Han L
    Acta Pharm Sin B; 2021 May; 11(5):1341-1354. PubMed ID: 34094838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
    Zhu D; Su Y; Fu B; Xu H
    Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
    Ju X; Miao T; Chen H; Ni J; Han L
    Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated inhibition of tissue-type plasminogen activator binding to the low-density lipoprotein receptor-related protein 1 as a potential beneficial modulator for stroke therapy.
    Klecker PH; Fritzen L; Mazura AD; Weggen S; Pietrzik CU
    J Cell Biochem; 2023 Jul; 124(7):1040-1049. PubMed ID: 37288821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
    Tashima T
    Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5).
    Goldeman C; Andersen M; Al-Robai A; Buchholtz T; Svane N; Ozgür B; Holst B; Shusta E; Hall VJ; Saaby L; Hyttel P; Brodin B
    Eur J Pharm Sci; 2021 Jan; 156():105577. PubMed ID: 33011235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury.
    Khalin I; Alyautdin R; Wong TW; Gnanou J; Kocherga G; Kreuter J
    Drug Deliv; 2016 Nov; 23(9):3520-3528. PubMed ID: 27278330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis.
    Yang YR; Xiong XY; Liu J; Wu LR; Zhong Q; Zhou K; Meng ZY; Liu L; Wang FX; Gong QW; Liao MF; Duan CM; Li J; Yang MH; Zhang Q; Gong CX; Yang QW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
    Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
    Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.
    Wan W; Cao L; Liu L; Zhang C; Kalionis B; Tai X; Li Y; Xia S
    J Neurochem; 2015 Jul; 134(2):382-93. PubMed ID: 25866188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
    Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease.
    Wang P; Zheng X; Guo Q; Yang P; Pang X; Qian K; Lu W; Zhang Q; Jiang X
    J Control Release; 2018 Jun; 279():220-233. PubMed ID: 29679667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage.
    Sun K; Fan J; Han J
    Acta Pharm Sin B; 2015 Jan; 5(1):8-24. PubMed ID: 26579420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.
    Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L
    J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in nanomedicines for the treatment of ischemic stroke.
    Li C; Sun T; Jiang C
    Acta Pharm Sin B; 2021 Jul; 11(7):1767-1788. PubMed ID: 34386320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.